PUBMED FOR HANDHELDS

Journal Abstract Search


504 related items for PubMed ID: 16868267

  • 1. Urinary cortisol and cortisol metabolite excretion in chronic fatigue syndrome.
    Jerjes WK, Taylor NF, Peters TJ, Wessely S, Cleare AJ.
    Psychosom Med; 2006; 68(4):578-82. PubMed ID: 16868267
    [Abstract] [Full Text] [Related]

  • 2. Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome.
    Jerjes WK, Peters TJ, Taylor NF, Wood PJ, Wessely S, Cleare AJ.
    J Psychosom Res; 2006 Feb; 60(2):145-53. PubMed ID: 16439267
    [Abstract] [Full Text] [Related]

  • 3. Diurnal patterns of salivary cortisol and cortisone output in chronic fatigue syndrome.
    Jerjes WK, Cleare AJ, Wessely S, Wood PJ, Taylor NF.
    J Affect Disord; 2005 Aug; 87(2-3):299-304. PubMed ID: 15922454
    [Abstract] [Full Text] [Related]

  • 4. Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment.
    Inder WJ, Prickett TC, Mulder RT.
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):343-8. PubMed ID: 15730417
    [Abstract] [Full Text] [Related]

  • 5. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia).
    Young AH, Sharpe M, Clements A, Dowling B, Hawton KE, Cowen PJ.
    Biol Psychiatry; 1998 Feb 01; 43(3):236-7. PubMed ID: 9494707
    [Abstract] [Full Text] [Related]

  • 6. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A, Hudson M, Jerjes W, Cleare AJ.
    Psychosom Med; 2005 Feb 01; 67(3):433-40. PubMed ID: 15911907
    [Abstract] [Full Text] [Related]

  • 7. Basal circadian and pulsatile ACTH and cortisol secretion in patients with fibromyalgia and/or chronic fatigue syndrome.
    Crofford LJ, Young EA, Engleberg NC, Korszun A, Brucksch CB, McClure LA, Brown MB, Demitrack MA.
    Brain Behav Immun; 2004 Jul 01; 18(4):314-25. PubMed ID: 15157948
    [Abstract] [Full Text] [Related]

  • 8. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome.
    Gaab J, Engert V, Heitz V, Schad T, Schürmeyer TH, Ehlert U.
    J Psychosom Res; 2004 Apr 01; 56(4):419-24. PubMed ID: 15094026
    [Abstract] [Full Text] [Related]

  • 9. Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome.
    Cleare AJ, O'Keane V, Miell JP.
    Psychoneuroendocrinology; 2004 Jul 01; 29(6):724-32. PubMed ID: 15110921
    [Abstract] [Full Text] [Related]

  • 10. Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome.
    Jerjes WK, Taylor NF, Wood PJ, Cleare AJ.
    Psychoneuroendocrinology; 2007 Feb 01; 32(2):192-8. PubMed ID: 17276605
    [Abstract] [Full Text] [Related]

  • 11. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J, Rohleder N, Heitz V, Engert V, Schad T, Schürmeyer TH, Ehlert U.
    Psychoneuroendocrinology; 2005 Feb 01; 30(2):188-98. PubMed ID: 15471616
    [Abstract] [Full Text] [Related]

  • 12. Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.
    Van Den Eede F, Moorkens G, Hulstijn W, Van Houdenhove B, Cosyns P, Sabbe BG, Claes SJ.
    Psychol Med; 2008 Jul 01; 38(7):963-73. PubMed ID: 17803834
    [Abstract] [Full Text] [Related]

  • 13. Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test.
    Papadopoulos A, Ebrecht M, Roberts AD, Poon L, Rohleder N, Cleare AJ.
    J Affect Disord; 2009 Jan 01; 112(1-3):289-94. PubMed ID: 18573538
    [Abstract] [Full Text] [Related]

  • 14. Comprehensive study of urinary cortisol metabolites in hyperthyroid and hypothyroid patients.
    Hoshiro M, Ohno Y, Masaki H, Iwase H, Aoki N.
    Clin Endocrinol (Oxf); 2006 Jan 01; 64(1):37-45. PubMed ID: 16402926
    [Abstract] [Full Text] [Related]

  • 15. Cortisol metabolism in depressed patients and healthy controls.
    Römer B, Lewicka S, Kopf D, Lederbogen F, Hamann B, Gilles M, Schilling C, Onken V, Frankhauser P, Deuschle M.
    Neuroendocrinology; 2009 Jan 01; 90(3):301-6. PubMed ID: 19713693
    [Abstract] [Full Text] [Related]

  • 16. Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome.
    Nater UM, Youngblood LS, Jones JF, Unger ER, Miller AH, Reeves WC, Heim C.
    Psychosom Med; 2008 Apr 01; 70(3):298-305. PubMed ID: 18378875
    [Abstract] [Full Text] [Related]

  • 17. Clinical burnout is not reflected in the cortisol awakening response, the day-curve or the response to a low-dose dexamethasone suppression test.
    Mommersteeg PM, Heijnen CJ, Verbraak MJ, van Doornen LJ.
    Psychoneuroendocrinology; 2006 Feb 01; 31(2):216-25. PubMed ID: 16150550
    [Abstract] [Full Text] [Related]

  • 18. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.
    Targher G, Bertolini L, Rodella S, Zoppini G, Zenari L, Falezza G.
    Clin Endocrinol (Oxf); 2006 Mar 01; 64(3):337-41. PubMed ID: 16487446
    [Abstract] [Full Text] [Related]

  • 19. Chronic fatigue syndrome and high allostatic load: results from a population-based case-control study in Georgia.
    Maloney EM, Boneva R, Nater UM, Reeves WC.
    Psychosom Med; 2009 Jun 01; 71(5):549-56. PubMed ID: 19414615
    [Abstract] [Full Text] [Related]

  • 20. Evidence of basal pituitary-adrenal overactivity in first episode, drug naïve patients with schizophrenia.
    Ryan MC, Sharifi N, Condren R, Thakore JH.
    Psychoneuroendocrinology; 2004 Sep 01; 29(8):1065-70. PubMed ID: 15219658
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.